The excess ultrasonic attenuation caused by adding glycogen and inorganic phosphate to liver homogenates has been studied to determine the underlying differences between attenuation coefficients of normal and diffusely diseased livers. Results show that glycogen has a higher than average specific absorption coefficient compared to other large molecular weight biomolecules. Since the glycogen content of liver can vary from 1%-10% of wet weight, this compound may have a major time-varying effect on the liver ultrasonic attenuation coefficient, even in normal subjects. In contrast, the excess attenuation of liver homogenate resulting from addition of inorganic phosphate was not significant at presumed physiological levels. The implications of these findings are discussed relative to tissue characterization efforts based on in vivo measurements of ultrasonic attenuation coefficients of liver.
INTRODUCTION
The ultrasonic attenuation coefficient of tissues has potential as a useful diagnostic or tissue characterization parameter. Glycogen is manufactured in the liver from available glucose and is stored in hepatocytes as high molecular weight (> 106) molecules. TM The stored glycogen represents available energy reserves for the liver and body, and can vary from less than 1% to approximately 10% of the liver wet weight, depending on "fasting or feasting" conditions. TM Since the normal liver dry weight is considered to be 20%-25% of the wet weight, •4'•6 glycogen can comprise a sizable fraction of the total liver dry weight. Thus the influence of glycogen on liver ultrasonic properties warrants investigation because large molecular weight biomolecules can have high specific absorption, l? and physiological levels of glycogen can approach a sizable fraction of total liver dry Whole tissue samples were taken from previously frozen calf liver. The plain homogenate samples were obtained by mixing whole liver with an equal amount by weight of chilled, degassed distilled water in a blender for 2 min. The mixture was degassed in a 25-to 28-in. Hg vacuum for 10 min to eliminate bubbles, and then pipetted into a pillboxshaped sample holder with clear, plastic-film acoustic windows. The homogenate was again degassed under vacuum for 20 min, and any remaining surface foam was skimmed off before covering and sealing the sample holder.
Glycogen and phosphate were dissolved slowly in distilled water to form the following solutions: 2-M, I-M, and 0.2-M phosphate ( 30%, 15 %, and 3 % by weight) and 10%, 6%, and 4% glycogen solutions. These solutions were mixed with equal weight of whole liver to produce homogenized samples, processed as described above. The attenuation coefficient for each homogenate was multiplied by 2 to correct for the dilution of liver and glycogen or phosphate.
The amplitude attenuation coefficient of the liver samples (with and without additives) was determined by a phase-insensitive radiation force technique as described in detail elsewhere. 8'9 Briefly, the sample, 1-2 cm thick, was inserted between a transducer and an absorbing target hung from a microbalance to measure insertion loss. Eight discrete frequencies were employed in the range of 1-12 MHz, 8'9 and all experiments were performed at room temperature, 20 øC-21 øC.
II. RESULTS
The excess attenuation divided by frequency for the added glycogen was linear with concentration (slope = 0.24-Np/cm/MHz/concentration at 5 MHz) in both distilled water and liver homogenate (Fig. 1 ) . Table I . The sum of the coefficients for the plain homogenate and the glycogen solution is also shown (circles) to demonstrate the additive property of the attenuation. In contrast, Fig. 3 shows the frequency-dependent attenuation for a high concentration of phosphate, 2 M, added to a liver homogenate. Here, the liver-phosphate attenuation is statistically higher (to a 95% confidence level using Student's t-test) than the summed value for homogenate and phosphate (circles). 
